Noah levek

Ms. Noah levek

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
NLNeriya Levran
Neriya Levran
NLNoah levek
Noah levek
BSBruria Sher
Bruria Sher
NGNoah Gruber
Noah Gruber
AAArnon Afek
Arnon Afek
OPOrit Pinhas-Hamiel
Orit Pinhas-Hamiel
Objective: The aim of this study was to evaluate the macronutrient and micronutrient intake and status in youth with type 1 diabetes mellitus (T1DM) following the consumption of a low-carbohydrate diet (LCD). Research Methods and Procedures: In a prospective intervention clinical trial, adolescents with T1DM using a continuous glucose monitoring device were enrolled. Following a cooking workshop, each participant received a personalized diet regime based on LCD (50–80 g carbohydrate/day). A Food Frequency Questionnaire was administered, and laboratory tests were taken before and 6 months following the intervention. Twenty participants were enrolled. Results: The median age was 17 years (15; 19), and the median diabetes duration was 10 years (8; 12). During the six-months intervention, carbohydrate intake decreased from 266 g (204; 316) to 87 g (68; 95) (p = 0.004). Energy intake, the energy percent from ultra-processed food, and fiber intake decreased (p = 0.001, p = 0.024, and p < 0.0001, respectively). These changes were accompanied by declines in BMI z-score (p = 0.019) and waist-circumference percentile (p = 0.007). Improvement was observed in the median HbA1c from 8.1% (7.5; 9.4) to 7.7% (6.9; 8.2) (p = 0.021). Significant declines below the DRI were shown in median intake levels of iron, calcium, vitamin B1, and folate. Conclusions: The LCD lowered ultra-processed food consumption, BMI z-scores and the indices of central obesity. However, LCDs require close nutritional monitoring due to the possibility of nutrient deficiencies.

28 January 2021 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
MRMarianna Rachmiel
Marianna Rachmiel
YLYael Lebenthal
Yael Lebenthal
KMKineret Mazor-Aronovitch
Kineret Mazor-Aronovitch
ABAvivit Brener
Avivit Brener
NLNoah levek
Noah levek
OPOrit Pinhas-Hamiel
Orit Pinhas-Hamiel

6 July 2016 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Open access
PDF file
OPOrit Pinhas-Hamiel
Orit Pinhas-Hamiel
ETEfrat Tisch
Efrat Tisch
NLNoah levek
Noah levek
RBRachel Frumkin Ben‐David
Rachel Frumkin Ben‐David
CGChana Graf‐Bar‐El
Chana Graf‐Bar‐El
LLLiat Lerner‐Geva
Liat Lerner‐Geva
Background: Sexual lifestyles including sexual activity, problems, satisfaction, and the formation and maintenance of relationships are greatly affected by physical health. Data are limited regarding the sexual lifestyle of adolescents and young adults with type 1 diabetes mellitus (T1DM). Fear of hypoglycemic episodes during sexual intercourse and intimacy issues can impact individuals with T1DM. The aim of this study was to assess sexual lifestyles of individuals with T1DM.Methods: Fifty‐three patients with T1DM, 27 (51%) males, mean ± SD age 27.9 ± 8.3 years completed the Hypoglycemia Fear Survey‐II and the Sex Practices and Concerns questionnaire.Results: Thirty‐seven (70%) reported they never or almost never had concerns in their sexual lifestyles that were related to their diabetes. None experienced severe hypoglycemia during sex, but 21 (40%) reported occasional mild hypoglycemic events. More than two‐thirds do not take any measures to prevent hypoglycemia before sex (decreasing insulin dose, snacks, and measuring blood glucose levels). Fear of hypoglycemia during sex was reported by 18 (35%); those who reported increased fear experienced mild hypoglycemic events during sex (61.1% vs 26.5%, P = .01), were singles (94.4% vs 64.7%, P = .02), and had higher scores on the Worries subscale of the Hypoglycemia Fear Survey‐II (42.8 ± 12.8 vs 34.9 ± 10.5, P = .04) compared with those who did not.Conclusions: Among young people with T1DM, most do not have concerns regarding sex that are related to their diabetes, and most do not take specific measures before or after sex. One‐third, however, fear of hypoglycemia during sex, mostly singles and those who experienced hypoglycemia in the past. Caregivers should be aware and address these concerns. Copyright © 2016 John Wiley & Sons, Ltd.

23 August 2023 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
MRMarianna Rachmiel
Marianna Rachmiel
YLYael Lebenthal
Yael Lebenthal
KMKineret Mazor-Aronovitch
Kineret Mazor-Aronovitch
ABAvivit Brener
Avivit Brener
NLNoah levek
Noah levek
OPOrit Pinhas-Hamiel
Orit Pinhas-Hamiel
Background and Aims: Achieving good glycemic control is a major challenge for adolescents with type 1 diabetes (TID). The introduction of the MiniMed 780G system, an advanced hybrid closed-loop (AHCL) that enables an automatic correction of insulin, gave hope for improved glycemic outcomes in adolescents. We assessed specific characteristics associated with glycemic measures in youth with T1D switching to Minimed 780G. Methods: This retrospective observational real-life multicenter study from the AWeSoMe Group assessed continuous glucose monitoring (CGM) metrics of 22 patients (59% females, median age 13.9 interquartile range [IQR 11,18] years), from a high socioeconomic background. CGM metrics were recorded for 2-week periods before AHCL, after 1, 3, 6 months, and at the end of follow-up (median 10.9 [IQR 5.4, 17.4] months). Delta-variables (Δ) were calculated as the difference between the end of follow-up and baseline. Results: Time in range (TIR) 70–180mg/dL increased from 65% [52, 72] to 75% [63, 80], P = 0.008, from baseline to end of follow-up. Time above range >180mg/dL decreased from 28% [20, 46] to 22% [14, 35], P = 0.047. Advanced pubertal stage was correlated with less improvement in ΔTAR >180mg/dL , r = 0.47, P = 0.05, and less CGM usage r = −0.57, P = 0.05. A longer disease duration was associated with less improvement in ΔTAR 180–250mg/dL , r = 0.48, P = 0.05. Lower pump site change frequency was associated with higher glucose management indicator, r = 0.5, P = 0.03, and lower TIR 70–180mg/dL r = −0.52, P = 0.08. Conclusion: The use of AHCL enabled improvements in TIR 70–180mg/dL in youth with T1D. More advanced pubertal stages, longer disease duration, and less compliance were associated with less improvement, stressing the need for continuous support, and re-education in this age group.

2 March 2021 in Pediatric Diabetes
Verified
Journal Article
Closed access
PDF file
KMKineret Mazor‐Aronovitch
Kineret Mazor‐Aronovitch
OPOrit Pinhas‐Hamiel
Orit Pinhas‐Hamiel
DPDikla Pivko‐Levy
Dikla Pivko‐Levy
DMDalit Modan‐Moses
Dalit Modan‐Moses
NLNoah levek
Noah levek
ZLZohar Landau
Zohar Landau

27 October 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
NLNeriya Levran
Neriya Levran
NLNoah levek
Noah levek
BSBruria Sher
Bruria Sher
EMElinor Mauda-Yitzhak
Elinor Mauda-Yitzhak
NGNoah Gruber
Noah Gruber
OPOrit Pinhas-Hamiel
Orit Pinhas-Hamiel
The Mediterranean diet (MED) is highly recommended. Medical nutrition therapy is the cornerstone of diabetes treatment. The primary outcome was to evaluate the change in micronutrient intake of youth with type 1 diabetes before and after a 6-month MED intervention; we also assessed adherence and glycemic control. Twenty adolescents, median age 18 years (interquartile range: 15.5–21), median diabetes duration 9 years (7–14), using continuous glucose monitoring devices, received personalized diet regimes based on MED. At 6 months post-intervention, the caloric intake remained unchanged; however, the carbohydrate proportion was lower (p = 0.058), and the intakes of some monounsaturated fats increased (p = 0.049). Sodium intake exceeded the recommended daily allowance by 250% (p = 0.653), before and after the intervention. For blood glucose, the percent TIR (time-in-range, 70–180 mg/dL) improved from 52% (38–60) to 63% (47–71) (p = 0.047). The total insulin dose decreased marginally, from 0.76 u/kg (0.64–0.97) to 0.72 u/kg (0.61–0.89) (p = 0.067). BMI z-score and waist circumference did not change (p = 0.316 and p = 0.161, respectively). Diastolic blood pressure percentile decreased from 73% (68–88) to 69% (50–79) (p = 0.028), and LDL cholesterol from 114 mg/dL (105–134) to 104 mg/dL (96–124) (p = 0.059). The Israeli Mediterranean diet screener score increased, from 8 (7–11) to 13 points (12–14) (p < 0.001). The MED-based intervention in youth with type 1 diabetes is feasible and leads to improvement in monounsaturated fat intake, TIR, and diastolic blood pressure. Other parameters show no change (caloric intake, BMI, and HbA1c).